From the Food and Drug Administration.
Schwetz
B A
BA
D000998:Antiviral Agents / Q000627:therapeutic use*; D001672:Biocompatible Materials; D002214:Capsules; D003952:Diagnostic Imaging / Q000295:instrumentation*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D020407:Internet; D007421:Intestine, Small / Q000473:pathology*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration; D014741:Video Recording
D000998:Antiviral Agents; D001672:Biocompatible Materials; D002214:Capsules; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a